Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma

SIMPLE SUMMARY: Different subtypes of lung cancer respond differently to treatment. To understand the signaling pathways that dictate the aggressive behavior of lung adenocarcinoma vs. lung squamous cell carcinoma, we performed a survival analysis that demonstrated that the protein Schlafen 12 corre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Al-Marsoummi, Sarmad, Pacella, Jonathan, Dockter, Kaylee, Soderberg, Matthew, Singhal, Sandeep K., Vomhof-DeKrey, Emilie E., Basson, Marc D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650563/
https://ncbi.nlm.nih.gov/pubmed/32987632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102738
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak